Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. E.M.D. (Ed) Schuuring

Publicaties

Authors' Reply “Non-Smoking and Non-Drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours”

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study

Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib

Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testing

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS)

Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors

Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom Analysis

Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer

Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA Workshop

Pers/media

Delivering molecular pathology at lower costs

Doelgerichte therapie bij longkanker

Naar een heel nieuw systeem voor kankerzorg en -diagnostiek

Commissie Beoordeling Diagnostiek

Organisatie moleculaire diagnostiek bij mammacarcinoom

At ESMO, Focusing on Non-Small Cell Lung Cancer

Longkanker: welke vorm heb ik?

25 jaar Moleculaire Diagnostiek binnen de Pathologie in Nederland

Moleculaire diagnostiek volop in beweging